1. The prognostic and diagnostic potential of kallikrein-related peptidases in ovarian cancer
   Maximilian Riedel et al, 2021, Expert Review of Molecular Diagnostics CrossRef
2. Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer
   Xiaocong Geng et al, 2017, PLOS ONE CrossRef
3. Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome
   Lakmali Munasinghage Silva et al, 2019, Molecular & Cellular Proteomics CrossRef
4. Prediction of therapy response in ovarian cancer: Where are we now?
   Khalid El Bairi et al, 2017, Critical Reviews in Clinical Laboratory Sciences CrossRef
5. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer
   Weiwei Gong et al, 2019, BMC Cancer CrossRef
6. A systematic review finds that spin or interpretation bias is abundant in evaluations of ovarian cancer biomarkers
   Mona Ghannad et al, 2019, Journal of Clinical Epidemiology CrossRef
7. The Role of Kallikrein 7 in Tumorigenesis
   Fengyi Xiang et al, 2022, Current Medicinal Chemistry CrossRef
8. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
   Weiwei Gong et al, 2020, Journal of Ovarian Research CrossRef
9. Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer
   Nancy Ahmed et al, 2016, Biological Chemistry CrossRef
10. Biomarkers in Gynecologic Tumors
    Selim Afsar, 2022, Biomarkers in Medicine CrossRef
11. Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer
    Daniela Loessner et al, 2018, Expert Opinion on Therapeutic Targets CrossRef